Regulatory mechanisms of PD-L1 expression in cancer cells Yongyu Shi Review 17 August 2018 Pages: 1481 - 1489
Absence of host NF-κB p50 induces murine glioblastoma tumor regression, increases survival, and decreases T-cell induction of tumor-associated macrophage M2 polarization Theresa BarberiAllison MartinAlan D. Friedman Original Article 21 July 2018 Pages: 1491 - 1503
A novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia Arjan A. van de LoosdrechtSandra van WeteringTanja D. de Gruijl Original Article Open access 23 July 2018 Pages: 1505 - 1518
Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells Gemma L. OwensMarcus J. PriceRichard J. Edmondson Original Article Open access 23 July 2018 Pages: 1519 - 1531
Safety and immunogenicity of a potential checkpoint blockade vaccine for canine melanoma Raj K. KurupatiXiangyang ZhouHildegund C. J. Ertl Original Article 26 July 2018 Pages: 1533 - 1544
High-grade glioma associated immunosuppression does not prevent immune responses induced by therapeutic vaccines in combination with Treg depletion Mario LöhrBenjamin FreitagMatthias Eyrich Original Article Open access 27 July 2018 Pages: 1545 - 1558
Epidermal growth factor receptor peptide vaccination induces cross-reactive immunity to human EGFR, HER2, and HER3 Hester A. DoyleRaymond A. KoskiMark J. Mamula Original Article 28 July 2018 Pages: 1559 - 1569
Older melanoma patients aged 75 and above retain responsiveness to anti-PD1 therapy: results of a retrospective single-institution cohort study Tony IbrahimChristine MateusCaroline Robert Original Article 28 July 2018 Pages: 1571 - 1578
Cytotoxic activity of effector T cells against cholangiocarcinoma is enhanced by self-differentiated monocyte-derived dendritic cells Aussara PanyaChutamas ThepmaleePa-thai Yenchitsomanus Original Article 28 July 2018 Pages: 1579 - 1588
Antitumor virotherapy using syngeneic or allogeneic mesenchymal stem cell carriers induces systemic immune response and intratumoral leukocyte infiltration in mice Álvaro Morales-MolinaStefano GamberaJavier García-Castro Original Article 31 July 2018 Pages: 1589 - 1602
Case report: Long-term survival of a pancreatic cancer patient immunized with an SVN-2B peptide vaccine Hiroaki ShimaGoro KutomiIchiro Takemasa Original Article Open access 01 August 2018 Pages: 1603 - 1609
3-Day monocyte-derived dendritic cells stimulated with a combination of OK432, TLR7/8 ligand, and prostaglandin E2 are a promising alternative for cancer immunotherapy Dag Heiro YiNadine StetterSilke Appel Original Article 01 August 2018 Pages: 1611 - 1620
Increased antitumor activities of glypican-3-specific chimeric antigen receptor-modified T cells by coexpression of a soluble PD1–CH3 fusion protein Zeyan PanShengmeng DiZonghai Li Original Article 04 August 2018 Pages: 1621 - 1634
Fusobacterium nucleatum promotes M2 polarization of macrophages in the microenvironment of colorectal tumours via a TLR4-dependent mechanism Ting ChenQing LiXiangsheng Fu Original Article 18 August 2018 Pages: 1635 - 1646
Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma Mark R. AlbertiniRichard K. YangPaul M. Sondel Clinical Trial Report 03 August 2018 Pages: 1647 - 1658